Trial intelligence / Profile preview

Rofecoxib and Bupivacaine for Post-Extraction Pain

NCT00050362Phase 2Completed

Sponsor
National Institute of Dental and Craniofacial Research
Start
Dec 2002
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of rofecoxib in postoperative pain, sponsored by National Institute of Dental and Craniofacial Research. Started Dec 2002; status: completed.

02

Drugs

rofecoxib
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00050362.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00050362.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call